Panitumumab plus radiotherapy for rectal cancer fails to meet endpoint

Preoperative panitumumab plus external radiotherapy did not meet a pre-specified pathologic complete response rate endpoint among patients with locally advanced rectal cancer, according to a study published in The Oncologist.
Cancer Therapy Advisor